Table 3: Summary of the reports of extrapyramidal symptoms.

Number of participants experiencing symptoms at week 4 and week 8* Cumulative number of participants experiencing symptoms during the study

Extrapyramidal symptomBaseline ( 𝑁 = 9 6 )Week 4 ( 𝑁 = 6 3 )Week 8 ( 𝑁 = 5 5 )Weeks 1–4 after baselineWeeks 1–8 after baseline

Akathisia3 (3.1%)4 (6.4%)1 (1.8%)1313
 Mild2311010
 Moderate11033

Hypokinesia22
 Mild00011
 Moderate11

Rigidity2 (2.1%)11 (17.5%)11 (20%)3134
 Mild28102426
 Moderate03178

Tremor3 (3.1%)2 (3.2%)5 (9.1%)1518
 Mild2251516
 Moderate10002

Acute dystonia
 Mild00000
 Moderate

Dyskinesia1
 Mild00001
 Moderate0

*Extrapyramidal symptoms could be reported as mild, moderate, or severe; there were no reports of a severe reaction.
Patients who experienced symptoms at least once during the study period.